查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1546205

全球蛋白質檢測市場

Protein Assays
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 308 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球蛋白質檢測市場將達到 37 億美元

全球蛋白質檢測市場預計 2023 年為 24 億美元，預計到 2030 年將達到 37 億美元，2023-2030 年分析期間複合年成長率為 6.3%。蛋白質檢測套件是本報告分析的細分市場之一，預計複合年成長率為 5.6%，到分析期結束時將達到 9.384 億美元。在分析期間，蛋白質檢測儀器及配件產業的複合年成長率預計為 6.2%。

美國市場預計將達6.372億美元，中國預計複合年成長率為5.9%

到 2023 年，美國蛋白質檢測市場預計將達到 6.372 億美元。中國作為全球第二大經濟體，預計2030年市場規模將達5.755億美元，2023年至2030年複合年成長率為5.9%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 5.7% 和 5.2%。在歐洲，德國的複合年成長率預計為 4.8%。

全球蛋白質檢測市場—主要趨勢與促進因素總結

不斷擴大的蛋白質檢測市場的潛力分析

蛋白質測定是生命科學研究的基本工具，可對各種生物樣本中的蛋白質進行定量和分析。這些測定對於理解蛋白質功能、結構和相互作用至關重要，對於新藥、診斷和治療方法的開發也至關重要。對蛋白質體學（蛋白質的大規模研究）的日益關注正在推動對蛋白質檢測的需求。在生物技術、製藥和臨床診斷等領域，蛋白質測定對於品管、藥物發現和疾病診斷至關重要。慢性病的增加和對個人化醫療的需求進一步強調了準確可靠的蛋白質檢測在現代醫療保健中的重要性。

科技進步如何影響市場？

技術進步在蛋白質檢測的發展中發揮關鍵作用。高通量檢測和自動化系統的發展徹底改變了這個領域，可以快速且準確地定量複雜生物樣品中的蛋白質。基於螢光和發光的檢測方法的創新提高了靈敏度和特異性，使研究人員能夠更準確地檢測低豐度蛋白質。微射流和實驗室晶片技術的整合也提高了各個領域研究人員的效率、擴充性和可訪問性。此外，生物資訊學和資料分析工具的進步正在促進複雜蛋白質資料的解釋，並進一步促進先進蛋白質測定在研究和臨床環境中的採用。

蛋白質檢測有哪些新應用？

蛋白質檢測擴大應用於個人化醫療、生物標記發現和免疫治療等新領域。在個人化醫療中，蛋白質檢測用於識別特定的生物標記物，以指南針對個別患者選擇標靶治療。此外，免疫療法的興起，特別是在癌症治療中，增加了對能夠評估免疫查核點蛋白表達水平的蛋白質檢測的需求，這在確定這些治療方法的有效性方面發揮著重要作用。此外，蛋白質檢測也被用來開發新的診斷工具，例如就地檢驗，可以在患者床邊提供快速、準確的結果。這些新應用的出現正在擴大蛋白質檢測的研究和臨床範圍以及效用。

市場成長的主要驅動力是什麼？

蛋白質檢測市場的成長受到多種因素的推動。對蛋白質組學的日益關注以及對研究蛋白質功能和相互作用的先進工具的需求是主要驅動力。高通量和自動化檢測等技術進步極大地提高了蛋白質定量的效率和準確性，促進了其在研究和臨床實踐中的採用。慢性病的流行和對個人化醫療的需求也推動了對可靠蛋白質檢測的需求。新的應用，特別是在生物標記發現和免疫治療方面，正在進一步擴大市場。此外，先進的資料分析工具和生物資訊學的整合增加了蛋白質檢測的效用，使其對現代生命科學研究至關重要。

受訪企業範例（11家知名企業）

  • Abcam PLC
  • Bio-Rad Laboratories, Inc.
  • Biovision Inc.
  • Cell Signaling Technology, Inc.
  • GE Healthcare Life Sciences
  • Geno Technology Inc.
  • Lonza Group AG
  • Merck KgaA
  • Novus Biologicals LLC
  • PerkinElmer, Inc.
  • Promega Corporation
  • Thermo Fisher Scientific, Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP14255

Global Protein Assays Market to Reach US$3.7 Billion by 2030

The global market for Protein Assays estimated at US$2.4 Billion in the year 2023, is expected to reach US$3.7 Billion by 2030, growing at a CAGR of 6.3% over the analysis period 2023-2030. Protein Assays Kits, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$938.4 Million by the end of the analysis period. Growth in the Protein Assays Instruments & Accessories segment is estimated at 6.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$637.2 Million While China is Forecast to Grow at 5.9% CAGR

The Protein Assays market in the U.S. is estimated at US$637.2 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$575.5 Million by the year 2030 trailing a CAGR of 5.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.7% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Global Protein Assays Market - Key Trends and Drivers Summarized

Analyzing the Potential: The Expanding Market for Protein Assays

Protein assays are fundamental tools in life sciences research, enabling the quantification and analysis of proteins in various biological samples. These assays are critical for understanding protein function, structure, and interactions, which are essential for developing new drugs, diagnostics, and therapies. The increasing focus on proteomics, the large-scale study of proteins, has significantly driven the demand for protein assays. In fields such as biotechnology, pharmaceuticals, and clinical diagnostics, protein assays are indispensable for quality control, drug discovery, and disease diagnosis. The growing prevalence of chronic diseases and the need for personalized medicine further underscore the importance of accurate and reliable protein assays in modern healthcare.

How Are Technological Advancements Influencing the Market?

Technological advancements have played a pivotal role in the evolution of protein assays. The development of high-throughput assays and automated systems has revolutionized the field, enabling the rapid and accurate quantification of proteins in complex biological samples. Innovations in fluorescence and luminescence-based assays have improved sensitivity and specificity, allowing researchers to detect low-abundance proteins with greater precision. The integration of microfluidics and lab-on-a-chip technologies has also enhanced the efficiency and scalability of protein assays, making them more accessible to researchers across various disciplines. Additionally, advancements in bioinformatics and data analysis tools have facilitated the interpretation of complex protein data, further driving the adoption of advanced protein assays in research and clinical settings.

What Are the Emerging Applications of Protein Assays?

Protein assays are increasingly being applied in emerging fields such as personalized medicine, biomarker discovery, and immunotherapy. In personalized medicine, protein assays are used to identify specific biomarkers that can guide the selection of targeted therapies for individual patients. The rise of immunotherapy, particularly in cancer treatment, has also driven the demand for protein assays that can assess the expression levels of immune checkpoint proteins, which are critical for determining the efficacy of these therapies. Additionally, protein assays are being used in the development of novel diagnostic tools, such as point-of-care tests, that provide rapid and accurate results at the patient’s bedside. These emerging applications are expanding the scope and utility of protein assays in both research and clinical practice.

What Are the Key Growth Drivers in the Market?

The growth in the protein assays market is driven by several factors. The increasing focus on proteomics and the need for advanced tools to study protein function and interactions are major drivers. Technological advancements, such as the development of high-throughput and automated assays, have significantly improved the efficiency and accuracy of protein quantification, driving their adoption in research and clinical settings. The growing prevalence of chronic diseases and the demand for personalized medicine have also spurred the need for reliable protein assays. Emerging applications, particularly in biomarker discovery and immunotherapy, are further expanding the market. Additionally, the integration of advanced data analysis tools and bioinformatics is enhancing the utility of protein assays, making them indispensable in modern life sciences research.

Select Competitors (Total 11 Featured) -

  • Abcam PLC
  • Bio-Rad Laboratories, Inc.
  • Biovision Inc.
  • Cell Signaling Technology, Inc.
  • GE Healthcare Life Sciences
  • Geno Technology Inc.
  • Lonza Group AG
  • Merck KgaA
  • Novus Biologicals LLC
  • PerkinElmer, Inc.
  • Promega Corporation
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • An Overview of Protein Assays Market
    • Protein Assays - Global Key Competitors Percentage Market Share in 2024 (E)
    • A Prelude into Market Leading Players
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increase in R&D Initiatives by Public and Private Companies is anticipated to Bolster Market Demand
    • Encouraging initiatives in Proteomics Research is Fuelling Worldwide Protein Assay Market
    • Rise in Biotech and Pharmaceutical R&D Expenditure Augurs Well for Market Growth
    • Global Pharmaceutical Industry: Breakdown of Total R&D Spend in USD Billion for years 2018, 2019, 2020, 2021, 2022
    • Increase in Cancer Prevalence: An Opportunity Indicator for Protein Assays Market
    • Increase in Technological Advancements to Fuel Growth in Protein Assay Market
    • Rising Demand in Biomedical research Propels Market Growth
    • Increasing Use in Drug Discovery and Development Expands Addressable Market Opportunity
    • Technological Advancements in Assay Sensitivity Strengthen Market Position
    • Growing Focus on Personalized Medicine Drives Adoption of Protein Assays
    • Surge in Demand for High-Throughput Screening Generates New Opportunities
    • Development of Multiplex Protein Assays Sustains Market Growth
    • Expanding Applications in Diagnostic Testing Throws Spotlight on Market Potential
    • Surge in Demand for Quantitative Proteomics Expands Market Horizons
    • Growing Awareness of Early Disease Detection Drives Market Adoption
    • Innovations in Microplate and Automated Assay Systems Generate New Market Opportunities
    • Rising Demand for Cost-Effective and Scalable Assay Solutions Throws Spotlight on Market Dynamics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Instruments & Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Instruments & Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Instruments & Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Disease Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Disease Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Disease Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Clinical Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Protein Assays Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Protein Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Protein Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Protein Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Absorbance-Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Absorbance-Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Absorbance-Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Colorimetric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Colorimetric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Colorimetric by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Fluorescence-Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Fluorescence-Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Fluorescence-Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: World 16-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: World 16-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Protein Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Protein Assays by Product - Reagents, Kits and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Protein Assays by Product - Reagents, Kits and Instruments & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Protein Assays by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments & Accessories for the Years 2014, 2024 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Protein Assays by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Disease Diagnosis and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: USA 16-Year Perspective for Protein Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: USA 16-Year Perspective for Protein Assays by Technology - Percentage Breakdown of Value Sales for Absorbance-Based, Colorimetric and Fluorescence-Based for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Protein Assays by Product - Reagents, Kits and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Protein Assays by Product - Reagents, Kits and Instruments & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Protein Assays by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments & Accessories for the Years 2014, 2024 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Canada 16-Year Perspective for Protein Assays by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Disease Diagnosis and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Canada 16-Year Perspective for Protein Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 65: Canada Recent Past, Current & Future Analysis for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Canada Historic Review for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Canada 16-Year Perspective for Protein Assays by Technology - Percentage Breakdown of Value Sales for Absorbance-Based, Colorimetric and Fluorescence-Based for the Years 2014, 2024 & 2030
  • JAPAN
    • Protein Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Protein Assays by Product - Reagents, Kits and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Protein Assays by Product - Reagents, Kits and Instruments & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Japan 16-Year Perspective for Protein Assays by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments & Accessories for the Years 2014, 2024 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Japan 16-Year Perspective for Protein Assays by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Disease Diagnosis and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 74: Japan Recent Past, Current & Future Analysis for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Japan 16-Year Perspective for Protein Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 77: Japan Recent Past, Current & Future Analysis for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Japan Historic Review for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Japan 16-Year Perspective for Protein Assays by Technology - Percentage Breakdown of Value Sales for Absorbance-Based, Colorimetric and Fluorescence-Based for the Years 2014, 2024 & 2030
  • CHINA
    • Protein Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 80: China Recent Past, Current & Future Analysis for Protein Assays by Product - Reagents, Kits and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Protein Assays by Product - Reagents, Kits and Instruments & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: China 16-Year Perspective for Protein Assays by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments & Accessories for the Years 2014, 2024 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: China Historic Review for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: China 16-Year Perspective for Protein Assays by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Disease Diagnosis and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 86: China Recent Past, Current & Future Analysis for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: China Historic Review for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: China 16-Year Perspective for Protein Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 89: China Recent Past, Current & Future Analysis for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: China Historic Review for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: China 16-Year Perspective for Protein Assays by Technology - Percentage Breakdown of Value Sales for Absorbance-Based, Colorimetric and Fluorescence-Based for the Years 2014, 2024 & 2030
  • EUROPE
    • Protein Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Protein Assays by Product - Reagents, Kits and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Protein Assays by Product - Reagents, Kits and Instruments & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Europe 16-Year Perspective for Protein Assays by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments & Accessories for the Years 2014, 2024 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Europe 16-Year Perspective for Protein Assays by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Disease Diagnosis and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 98: Europe Recent Past, Current & Future Analysis for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Europe 16-Year Perspective for Protein Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 101: Europe Recent Past, Current & Future Analysis for Protein Assays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for Protein Assays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Europe 16-Year Perspective for Protein Assays by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 104: Europe Recent Past, Current & Future Analysis for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Europe Historic Review for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Europe 16-Year Perspective for Protein Assays by Technology - Percentage Breakdown of Value Sales for Absorbance-Based, Colorimetric and Fluorescence-Based for the Years 2014, 2024 & 2030
  • FRANCE
    • Protein Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 107: France Recent Past, Current & Future Analysis for Protein Assays by Product - Reagents, Kits and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: France Historic Review for Protein Assays by Product - Reagents, Kits and Instruments & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: France 16-Year Perspective for Protein Assays by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments & Accessories for the Years 2014, 2024 & 2030
    • TABLE 110: France Recent Past, Current & Future Analysis for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: France Historic Review for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: France 16-Year Perspective for Protein Assays by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Disease Diagnosis and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 113: France Recent Past, Current & Future Analysis for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: France Historic Review for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: France 16-Year Perspective for Protein Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 116: France Recent Past, Current & Future Analysis for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: France Historic Review for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: France 16-Year Perspective for Protein Assays by Technology - Percentage Breakdown of Value Sales for Absorbance-Based, Colorimetric and Fluorescence-Based for the Years 2014, 2024 & 2030
  • GERMANY
    • Protein Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 119: Germany Recent Past, Current & Future Analysis for Protein Assays by Product - Reagents, Kits and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for Protein Assays by Product - Reagents, Kits and Instruments & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Germany 16-Year Perspective for Protein Assays by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments & Accessories for the Years 2014, 2024 & 2030
    • TABLE 122: Germany Recent Past, Current & Future Analysis for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Germany Historic Review for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Germany 16-Year Perspective for Protein Assays by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Disease Diagnosis and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 125: Germany Recent Past, Current & Future Analysis for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Germany Historic Review for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Germany 16-Year Perspective for Protein Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 128: Germany Recent Past, Current & Future Analysis for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Germany Historic Review for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Germany 16-Year Perspective for Protein Assays by Technology - Percentage Breakdown of Value Sales for Absorbance-Based, Colorimetric and Fluorescence-Based for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 131: Italy Recent Past, Current & Future Analysis for Protein Assays by Product - Reagents, Kits and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for Protein Assays by Product - Reagents, Kits and Instruments & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Italy 16-Year Perspective for Protein Assays by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments & Accessories for the Years 2014, 2024 & 2030
    • TABLE 134: Italy Recent Past, Current & Future Analysis for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Italy Historic Review for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Italy 16-Year Perspective for Protein Assays by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Disease Diagnosis and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 137: Italy Recent Past, Current & Future Analysis for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Italy Historic Review for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Italy 16-Year Perspective for Protein Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 140: Italy Recent Past, Current & Future Analysis for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Italy Historic Review for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Italy 16-Year Perspective for Protein Assays by Technology - Percentage Breakdown of Value Sales for Absorbance-Based, Colorimetric and Fluorescence-Based for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Protein Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 143: UK Recent Past, Current & Future Analysis for Protein Assays by Product - Reagents, Kits and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for Protein Assays by Product - Reagents, Kits and Instruments & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: UK 16-Year Perspective for Protein Assays by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments & Accessories for the Years 2014, 2024 & 2030
    • TABLE 146: UK Recent Past, Current & Future Analysis for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: UK Historic Review for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: UK 16-Year Perspective for Protein Assays by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Disease Diagnosis and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 149: UK Recent Past, Current & Future Analysis for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: UK Historic Review for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: UK 16-Year Perspective for Protein Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 152: UK Recent Past, Current & Future Analysis for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: UK Historic Review for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: UK 16-Year Perspective for Protein Assays by Technology - Percentage Breakdown of Value Sales for Absorbance-Based, Colorimetric and Fluorescence-Based for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Protein Assays by Product - Reagents, Kits and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Europe Historic Review for Protein Assays by Product - Reagents, Kits and Instruments & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of Europe 16-Year Perspective for Protein Assays by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments & Accessories for the Years 2014, 2024 & 2030
    • TABLE 158: Rest of Europe Recent Past, Current & Future Analysis for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Europe Historic Review for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Europe 16-Year Perspective for Protein Assays by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Disease Diagnosis and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Europe Recent Past, Current & Future Analysis for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Europe Historic Review for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Europe 16-Year Perspective for Protein Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 164: Rest of Europe Recent Past, Current & Future Analysis for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Rest of Europe Historic Review for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Rest of Europe 16-Year Perspective for Protein Assays by Technology - Percentage Breakdown of Value Sales for Absorbance-Based, Colorimetric and Fluorescence-Based for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Protein Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Protein Assays by Product - Reagents, Kits and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Asia-Pacific Historic Review for Protein Assays by Product - Reagents, Kits and Instruments & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Asia-Pacific 16-Year Perspective for Protein Assays by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments & Accessories for the Years 2014, 2024 & 2030
    • TABLE 170: Asia-Pacific Recent Past, Current & Future Analysis for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Asia-Pacific Historic Review for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Asia-Pacific 16-Year Perspective for Protein Assays by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Disease Diagnosis and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 173: Asia-Pacific Recent Past, Current & Future Analysis for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Asia-Pacific Historic Review for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Asia-Pacific 16-Year Perspective for Protein Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 176: Asia-Pacific Recent Past, Current & Future Analysis for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Asia-Pacific Historic Review for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Asia-Pacific 16-Year Perspective for Protein Assays by Technology - Percentage Breakdown of Value Sales for Absorbance-Based, Colorimetric and Fluorescence-Based for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 179: Rest of World Recent Past, Current & Future Analysis for Protein Assays by Product - Reagents, Kits and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Rest of World Historic Review for Protein Assays by Product - Reagents, Kits and Instruments & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Rest of World 16-Year Perspective for Protein Assays by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments & Accessories for the Years 2014, 2024 & 2030
    • TABLE 182: Rest of World Recent Past, Current & Future Analysis for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Rest of World Historic Review for Protein Assays by Application - Drug Discovery & Development, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Rest of World 16-Year Perspective for Protein Assays by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Disease Diagnosis and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 185: Rest of World Recent Past, Current & Future Analysis for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Rest of World Historic Review for Protein Assays by End-Use - Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Rest of World 16-Year Perspective for Protein Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Clinical Laboratories, Hospitals and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 188: Rest of World Recent Past, Current & Future Analysis for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Rest of World Historic Review for Protein Assays by Technology - Absorbance-Based, Colorimetric and Fluorescence-Based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Rest of World 16-Year Perspective for Protein Assays by Technology - Percentage Breakdown of Value Sales for Absorbance-Based, Colorimetric and Fluorescence-Based for the Years 2014, 2024 & 2030

IV. COMPETITION